Roche presents five-year survival outcomes for Tecentriq plus chemotherapy in ES-SCLC
IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Atezolizumab
Roche gets positive CHMP opinion for Tecentriq plus Avastin to treat liver cancer
The recommendation from the CHMP is based on results from the Phase III IMbrave150 study, which showed that Tecentriq in…
Roche gets US FDA approval for Tecentriq combo to treat advanced melanoma
The approval is based on results from the Phase III IMspire150 study, in which the addition of Tecentriq to Cotellic and Zelboraf…
Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast…
Atezolizumbab is the first immunotherapy drug to be approved globally for treatment of unresectable locally advanced and…
Roche’s Atezolizumab receives DCGI approval for small cell lung cancer treatment in India
Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of ES-SCLC when given…